NCT05791370

Brief Summary

A parallel intervention was conducted to test the effect of consuming diets enriched with red palm olein (RPOO), extra virgin coconut oil (EVCO) and extra virgin olive oil (EVOO; positive control) in centrally obese individuals over a 12-week period. Following the screening of the subjects' health status, including their biochemical and lipid profiles, the subjects completed a 12-week dietary intervention. Both fasting blood and urine samples were collected at baseline (day 0) and endpoint (week 12); measurements were taken in duplicates. All data collected were blinded to the investigators by an independent third party until the completion of the analysis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
156

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2019

Completed
3.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2022

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

December 20, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

March 30, 2023

Completed
Last Updated

March 30, 2023

Status Verified

March 1, 2023

Enrollment Period

5 months

First QC Date

December 20, 2022

Last Update Submit

March 28, 2023

Conditions

Keywords

red palm oleinextra virgin coconut oilextra virgin olive oilhigh sensitivity C-reactive proteininflammationobesity

Outcome Measures

Primary Outcomes (1)

  • hs-C reactive protein (hsCRP)

    Changes in the mean of plasma hs-CRP at the endpoint relative to the baseline. Plasma hsCRP will be measured using an immunoturbidimetric method, fibrinogen by Clauss method (Dade)

    12 weeks

Secondary Outcomes (30)

  • Plasma lipid profile: Total cholesterol (mmol/L)

    12 weeks

  • Plasma lipid profile: LDL cholesterol (mmol/L)

    12 weeks

  • Plasma lipid profile: HDL cholesterol (mmol/L)

    12 weeks

  • Plasma lipid profile: Triacylglycerol (mmol/L)

    12 weeks

  • Plasma lipid profile: Apolipoprotein B-100 (g/L)

    12 weeks

  • +25 more secondary outcomes

Study Arms (3)

Red palm olein

EXPERIMENTAL

Meals enriched with Red palm olein

Dietary Supplement: A 12-week parallel dietary intervention

Extra virgin coconut oil

EXPERIMENTAL

Meals enriched with Extra virgin coconut oil

Dietary Supplement: A 12-week parallel dietary intervention

Extra virgin olive oil

EXPERIMENTAL

Meals enriched with Extra virgin olive oil

Dietary Supplement: A 12-week parallel dietary intervention

Interventions

Subjects consumed 3 isocaloric meals prepared with the 3 oils for a duration of 12 weeks. The test meals were given for 5-day a week and contained 27-30% energy fat, with 2/3 (20% energy fat) replaced by experimental fat.

Extra virgin coconut oilExtra virgin olive oilRed palm olein

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • aged 25-45 years
  • waist circumference ≥ 90 cm for men and ≥ 80 cm for women

You may not qualify if:

  • BMI ≤ 18.5 kg/m2
  • medical history of cardiovascular diseases
  • positive for diabetes or dyslipidemia
  • diagnosed with chronic illness
  • plasma total cholesterol \> 6.5 mmol/L
  • triacylglycerol \>4.5 mmol/L
  • on antihypertensive or lipid-lowering medication
  • lactating
  • pregnant
  • smoking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Malaysian Palm Oil Board

Kajang, Selangor, 43000, Malaysia

Location

Related Publications (1)

  • Teng KT, Loganathan R, Chew BH, Khang TF. Diverse impacts of red palm olein, extra virgin coconut oil and extra virgin olive oil on cardiometabolic risk markers in individuals with central obesity: a randomised trial. Eur J Nutr. 2024 Jun;63(4):1225-1239. doi: 10.1007/s00394-024-03338-6. Epub 2024 Feb 19.

MeSH Terms

Conditions

InflammationObesity

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and Symptoms

Study Officials

  • Kim Tiu Teng, PhD

    Malaysia Palm Oil Board

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
All data collected were blinded to the investigators by an independent third party until the completion of the analysis. The efficacy of the blinding procedure was assessed by evaluating the compliance of participants using the visual analogue scale to the experimental diets.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: We recruited a total of 156 overweight individuals, aged 25-45 years, with waist circumference ≥ 90 cm for men and ≥ 80 cm for women in a single-blind 3-arm randomised controlled trial. The participants consumed isocaloric diets (\~ 2400 kcal) enriched with red palm olein (RPOO), extra virgin coconut oil (EVCO) and extra virgin olive oil (EVOO, as a control) for a 12-week duration
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 20, 2022

First Posted

March 30, 2023

Study Start

January 1, 2019

Primary Completion

May 30, 2019

Study Completion

November 30, 2022

Last Updated

March 30, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

There is no plan to share the individual participant data , provided requested specifically for scientific analysis purposes

Locations